HUMAN GENOME SCI (NASDAQ:HGSI)
27.38
+0.16 (0.59%)
| HUMAN GENOME SCI (NASDAQ:HGSI) Delayed : |
| Previous Close |
$27.22 |
|
52 Week High |
$29.48 |
|
| Open |
$26.99 |
|
52 Week Low |
$0.45 |
| Day High |
$27.59 |
|
P/E |
N/A |
| Day Low |
$26.55 |
|
EPS |
$-0.36 |
| Volume |
5,929,911 |
|
|
|
| More HGSI Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on HGSI
-
Nov 16, 2009 07:24 AM
Human Genome (HGSI) Receives U.S. FDA Response Letter for Anthrax Treatment Raxibacumab
-
Nov 3, 2009 11:33 AM
JPMorgan Boosts Target on Human Genome (HGSI) to $35
-
Nov 3, 2009 10:28 AM
Goldman Sachs Lifts Tgt on Human Genome Sciences (HGSI) to $30, Sees As Acquisition Candidate
-
Nov 3, 2009 08:49 AM
Human Genome (HGSI) volatility low at 73 after announcing positive data
-
Nov 2, 2009 01:48 PM
Unusual 11 Mid-Day Movers 11/02: HGSI, EAC, IUSA, VRTX Higher; CIT, YRCW, GTXI, CPF Lower
View All Reports
StreetInsider Reports on HGSI by Category
-
Nov 17, 2009 05:02 AM
BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
-
Nov 16, 2009 12:26 PM
Direction of Cholesterol Debate Could Benefit Abbott Labs
-
Nov 12, 2009 01:46 PM
Best Performing Stocks Since 3/9/09 and 10/9/07
-
Nov 5, 2009 11:53 AM
Lower Third Quarter Loss for Human Genome
-
Nov 5, 2009 05:36 AM
Cramer's Lightning Round - Goldman Goes Higher but Not Today (11/4/09)
View All Blogs
Comments on HGSI
No comments are currently available.
on Oct 20, 2009
at 09:25 AM clinical trials How do you get into clinical trials? dmhc24@aol.com
Article: Human Genome (HGSI) and Glaxo (GSK) Announce BLISS-52 Lupus Treatment Results
on Oct 15, 2009
at 12:26 PM HGSI BUY will get approved on lupus and go thru roof!
Article: Goldman Sachs Resumes Human Genome Sciences (HGSI) at Buy, Sees As Potential Takeover Target
on Jul 20, 2009
at 12:50 PM Why vaselate? Your investment professionals could command a greater measure of respect if they would simply issue a statement acknowledging the bad call made on HGSI instead of switching to the buy side after the stock has moved up 193 percent. I understand the difficulties following a difficult stock like HGSI, however, I do not understand the way investment opinions are haphazardly published by your company.
Article: Citi & Lazard Capital Jump on Bandwagon - Upgrade Human Genome Sciences (HGSI)
on Jun 5, 2009
at 02:06 PM hgsi it's time to add hgsi to your long portfolio NOW before it is too late....buy it TODAY on the dip...
Article: ThinkEquity Downgrades Human Genome Sciences (HGSI) to Source of Funds
on Jun 5, 2009
at 02:00 PM Analysts Seriously, isn't now the time in financial history to do away with analysts?
Article: ThinkEquity Downgrades Human Genome Sciences (HGSI) to Source of Funds